ANIFLOzid-600
Description_Effects
ANIFLOzid-600 contains Linezolid 600 mg, an oxazolidinone-class antibiotic used to treat a wide range of serious bacterial infections, particularly those caused by Gram-positive bacteria. It is highly effective against infections such as pneumonia, complicated and uncomplicated skin and soft tissue infections, and infections caused by resistant strains like MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus). Linezolid works by inhibiting bacterial protein synthesis, a vital function required for bacteria to grow and multiply. By stopping this process, the medicine halts the spread of infection and supports the immune system in eliminating the bacteria. ANIFLOzid-600 is often prescribed when other antibiotics fail or when resistant organisms are identified. It can be taken orally or given intravenously depending on the severity of the infection. Patients often start to feel better within a few days of treatment, but it is crucial to complete the full course of medication even if symptoms improve early, to prevent reinfection and the development of antibiotic resistance. Common side effects may include headache, nausea, diarrhea, and dizziness. Long-term or high-dose use may require blood monitoring to detect potential issues such as low blood cell counts or lactic acidosis. It should be used with caution in patients taking serotonergic drugs due to the risk of serotonin syndrome.
